false Q2 --12-31 2026-06-30 0001899005 0001899005 2026-01-01 2026-06-30 0001899005 2025-01-01 2025-06-30 0001899005 bmr:GeneralAndAdministrativeMember 2025-01-01 2025-06-30 0001899005 bmr:GeneralAndAdministrativeMember 2026-01-01 2026-06-30 0001899005 bmr:SalesAndMarketingMember 2025-01-01 2025-06-30 0001899005 bmr:SalesAndMarketingMember 2026-01-01 2026-06-30 0001899005 bmr:ResearchAndDevelopmentMember 2025-01-01 2025-06-30 0001899005 bmr:ResearchAndDevelopmentMember 2026-01-01 2026-06-30 0001899005 2026-06-30 0001899005 srt:MaximumMember 2025-06-30 0001899005 srt:MinimumMember 2025-06-30 0001899005 srt:MaximumMember 2026-06-30 0001899005 srt:MinimumMember 2026-06-30 0001899005 srt:MaximumMember 2025-01-01 2025-06-30 0001899005 srt:MinimumMember 2025-01-01 2025-06-30 0001899005 srt:MaximumMember 2026-01-01 2026-06-30 0001899005 srt:MinimumMember 2026-01-01 2026-06-30 0001899005 us-gaap:CommonStockMember 2025-01-01 2025-06-30 0001899005 us-gaap:CommonStockMember 2026-01-01 2026-06-30 0001899005 bmr:ExercisePrice502Member 2026-01-01 2026-06-30 0001899005 bmr:ExercisePrice502Member 2026-06-30 0001899005 bmr:ExercisePrice496Member 2026-01-01 2026-06-30 0001899005 bmr:ExercisePrice496Member 2026-06-30 0001899005 bmr:ExercisePrice400Member 2026-01-01 2026-06-30 0001899005 bmr:ExercisePrice400Member 2026-06-30 0001899005 bmr:ExercisePrice359Member 2026-01-01 2026-06-30 0001899005 bmr:ExercisePrice359Member 2026-06-30 0001899005 bmr:ExercisePrice320Member 2026-01-01 2026-06-30 0001899005 bmr:ExercisePrice320Member 2026-06-30 0001899005 bmr:ExercisePrice314Member 2026-01-01 2026-06-30 0001899005 bmr:ExercisePrice314Member 2026-06-30 0001899005 bmr:ExercisePrice298Member 2026-01-01 2026-06-30 0001899005 bmr:ExercisePrice298Member 2026-06-30 0001899005 bmr:ExercisePrice297Member 2026-01-01 2026-06-30 0001899005 bmr:ExercisePrice297Member 2026-06-30 0001899005 bmr:ExercisePrice287Member 2026-01-01 2026-06-30 0001899005 bmr:ExercisePrice287Member 2026-06-30 0001899005 bmr:ExercisePrice243Member 2026-01-01 2026-06-30 0001899005 bmr:ExercisePrice243Member 2026-06-30 0001899005 bmr:ExercisePrice240Member 2026-01-01 2026-06-30 0001899005 bmr:ExercisePrice240Member 2026-06-30 0001899005 bmr:ExercisePrice230Member 2026-01-01 2026-06-30 0001899005 bmr:ExercisePrice230Member 2026-06-30 0001899005 bmr:ExercisePrice194Member 2026-01-01 2026-06-30 0001899005 bmr:ExercisePrice194Member 2026-06-30 0001899005 bmr:ExercisePrice188Member 2026-01-01 2026-06-30 0001899005 bmr:ExercisePrice188Member 2026-06-30 0001899005 bmr:ExercisePrice184Member 2026-01-01 2026-06-30 0001899005 bmr:ExercisePrice184Member 2026-06-30 0001899005 bmr:ExercisePrice183Member 2026-01-01 2026-06-30 0001899005 bmr:ExercisePrice183Member 2026-06-30 0001899005 bmr:ExercisePrice174Member 2026-01-01 2026-06-30 0001899005 bmr:ExercisePrice174Member 2026-06-30 0001899005 bmr:ExercisePrice165Member 2026-01-01 2026-06-30 0001899005 bmr:ExercisePrice165Member 2026-06-30 0001899005 bmr:ExercisePrice148Member 2026-01-01 2026-06-30 0001899005 bmr:ExercisePrice148Member 2026-06-30 0001899005 bmr:ExercisePrice114Member 2026-01-01 2026-06-30 0001899005 bmr:ExercisePrice114Member 2026-06-30 0001899005 bmr:ExercisePrice0000Member 2026-01-01 2026-06-30 0001899005 bmr:ExercisePrice0000Member 2026-06-30 0001899005 srt:BoardOfDirectorsChairmanMember 2025-06-30 0001899005 srt:BoardOfDirectorsChairmanMember 2025-01-01 2025-06-30 0001899005 srt:BoardOfDirectorsChairmanMember 2024-12-31 0001899005 srt:BoardOfDirectorsChairmanMember 2024-12-31 2024-12-31 0001899005 srt:BoardOfDirectorsChairmanMember 2026-06-30 0001899005 srt:BoardOfDirectorsChairmanMember 2026-01-01 2026-06-30 0001899005 srt:BoardOfDirectorsChairmanMember 2025-12-31 0001899005 srt:BoardOfDirectorsChairmanMember 2025-12-31 2025-12-31 0001899005 us-gaap:CommonStockMember 2026-05-06 2026-05-06 0001899005 2025-06-30 0001899005 2024-12-31 0001899005 2025-12-31 0001899005 us-gaap:RetainedEarningsMember 2026-06-30 0001899005 us-gaap:AdditionalPaidInCapitalMember 2026-06-30 0001899005 us-gaap:CommonStockMember 2026-06-30 0001899005 us-gaap:RetainedEarningsMember 2026-01-01 2026-06-30 0001899005 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-06-30 0001899005 us-gaap:RetainedEarningsMember 2025-12-31 0001899005 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001899005 us-gaap:CommonStockMember 2025-12-31 0001899005 us-gaap:RetainedEarningsMember 2025-06-30 0001899005 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0001899005 us-gaap:CommonStockMember 2025-06-30 0001899005 us-gaap:RetainedEarningsMember 2025-01-01 2025-06-30 0001899005 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-06-30 0001899005 us-gaap:RetainedEarningsMember 2024-12-31 0001899005 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001899005 us-gaap:CommonStockMember 2024-12-31 iso4217:USD iso4217:USD xbrli:shares xbrli:pure xbrli:shares iso4217:ILS xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 6-K

 

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

 

For the month of August 2026

 

Commission file number: 001-41523

 

BEAMR IMAGING LTD.

(Translation of registrant’s name into English)

 

10 HaManofim Street

Herzeliya, 4672561, Israel

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒         Form 40-F

 

Exhibits 99.2 and Exhibit 99.3 of this Form 6-K are hereby incorporated by reference into the registrant’s Registration Statements on Form S-8 (File No. 333-272779 and 333-280576) and Form F-3 (File No. 333-277787), to be a part thereof from the date on which this report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.

 

 

 

 

 

 

On August 11, 2026, Beamr Imaging Ltd. (the “Company”) issued a press release entitled “Beamr Issues Q2-2026 CEO Letter to Shareholders: Expanding Our Reach into AV Teams”. In addition, on the same day, the Company issued condensed consolidated interim financial statements (unaudited) as of June 30, 2026 together with the Company’s Operating and Financial Review and Prospects for the same period.

 

Attached hereto and incorporated by reference herein are the following exhibits:

 

99.1   Press Release, dated August 11, 2026.
99.2   Condensed Consolidated Interim Financial Statements (unaudited) as of June 30, 2026.
99.3   Operating and Financial Review and Prospects as of June 30, 2026.
101.INS   Inline XBRL Instance Document
101.SCH   Inline XBRL Taxonomy Extension Schema Document
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  Beamr Imaging Ltd.
   
Date: August 11, 2026 By: /s/ Sharon Carmel
  Name: Sharon Carmel
  Title: Chief Executive Officer

 

2

 


ATTACHMENTS / EXHIBITS

ATTACHMENTS / EXHIBITS

PRESS RELEASE, DATED AUGUST 11, 2026

CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (UNAUDITED) AS OF JUNE 30, 2026

OPERATING AND FINANCIAL REVIEW AND PROSPECTS AS OF JUNE 30, 2026

XBRL SCHEMA FILE

XBRL CALCULATION FILE

XBRL DEFINITION FILE

XBRL LABEL FILE

XBRL PRESENTATION FILE

IDEA: R1.htm

IDEA: R2.htm

IDEA: R3.htm

IDEA: R4.htm

IDEA: R5.htm

IDEA: R6.htm

IDEA: R7.htm

IDEA: R8.htm

IDEA: R9.htm

IDEA: R10.htm

IDEA: R11.htm

IDEA: R12.htm

IDEA: R13.htm

IDEA: R14.htm

IDEA: R15.htm

IDEA: R16.htm

IDEA: R17.htm

IDEA: R18.htm

IDEA: R19.htm

IDEA: R20.htm

IDEA: R21.htm

IDEA: FilingSummary.xml

IDEA: MetaLinks.json

IDEA: ea0300235-6k_beamr_htm.xml